Goodwin-Led Biotech Co. Moderna Sets Sights On $500M IPO
Massachusetts-based biopharmaceutical firm Moderna Inc. on Wednesday said it expects to bring in $500 million at the midpoint of its price range for its upcoming initial public offering, led by Goodwin...To view the full article, register now.
Already a subscriber? Click here to view full article